Cleft palate has a strong genetic component, but it is not purely genetic. About 70% of cases occur as isolated conditions without any associated syndrome, and these typically result from a combination of multiple genes interacting with environmental factors during early pregnancy. The remaining 30% are linked to specific genetic syndromes with clearer inheritance patterns.
How Genes Influence Palate Formation
During the first trimester, the roof of the mouth forms when two shelves of tissue grow toward each other and fuse. This process depends on precise signaling between genes that control cell behavior. One of the most studied genes in cleft palate is IRF6, which helps regulate the transformation of surface cells into the connective tissue needed for the two palatal shelves to merge. When IRF6 functions normally, it triggers a chain of molecular events that allow the tissue edges to dissolve and knit together. When it doesn’t, the shelves may fail to fuse completely, leaving a gap.
IRF6 is far from the only gene involved. Researchers have identified variants in dozens of genes that each contribute a small amount of risk. No single gene causes most cases of cleft palate on its own. Instead, it follows what geneticists call a “multifactorial threshold” model: risk accumulates from multiple genetic variants plus environmental exposures, and a cleft forms only when the combined burden crosses a certain threshold.
Syndromic Versus Nonsyndromic Clefts
The 30% of cleft cases tied to recognized genetic syndromes tend to follow more predictable inheritance patterns. Van der Woude syndrome is the most common, caused by mutations in the IRF6 gene in most cases and the GRHL3 gene in about 5%. It follows an autosomal dominant pattern, meaning a child needs only one copy of the altered gene (from one parent) to be affected. A parent with Van der Woude syndrome has a 50% chance of passing the gene variant to each child, though the severity varies widely.
Another well-known condition is 22q11.2 deletion syndrome (sometimes called DiGeorge syndrome), where a small piece of chromosome 22 is missing. The deletion is present in 5 to 8% of children born with cleft lip or palate. Among those who carry it, palatal problems range from a subtle submucosal cleft (16% of cases) to a full open cleft palate (11%), with velopharyngeal insufficiency (difficulty closing off the nasal passage during speech) occurring in 24 to 80%.
The nonsyndromic 70% of cases are harder to predict. These clefts arise from the combined effects of common gene variants that individually carry very small risks. A family may have no history of clefting at all, yet a child is born with a cleft palate because they happened to inherit an unlucky combination of otherwise harmless genetic variations.
Recurrence Risk for Families
A large Danish study tracking over 54,000 relatives of people with oral clefts provides the clearest picture of family risk. For isolated cleft palate specifically, the recurrence risk breaks down like this:
- Offspring of an affected parent: 4.2%
- Siblings of an affected child: 3.3%
- Parents of an affected child (reflecting their own risk): 2.1%
For second-degree relatives (aunts, uncles, grandparents), the risk drops to around 0.8%, and for third-degree relatives (cousins), it falls further to about 0.6%. These numbers apply to nonsyndromic clefts. If a specific syndrome is involved, the risk depends on that syndrome’s inheritance pattern and may be considerably higher.
The overall recurrence risk for first-degree relatives, around 3.5%, is much higher than the general population risk (roughly 1 in 700 births for all oral clefts combined) but still means that the large majority of siblings and children of affected individuals will not have a cleft.
Environmental Factors That Interact With Genetics
Genes set the stage, but environmental exposures during the critical weeks of palate formation can tip the balance. Maternal smoking is one of the best-documented risk factors. A meta-analysis found that smoking during pregnancy increases the odds of cleft lip or palate by about 42%, with a dose-response relationship: the heaviest smokers faced a 45% increase compared to 20% for the lightest smokers. For cleft palate alone, the increased risk was around 25%.
Pre-gestational diabetes is another recognized risk factor, though precise numbers are harder to pin down. Certain anti-seizure medications also raise risk significantly. Topiramate at doses above 100 mg daily during early pregnancy is associated with a roughly fivefold increase in oral cleft risk. At lower doses, the risk is smaller but still elevated. These medications appear to interfere with the same developmental pathways that genetic variants disrupt.
Even the molecular mechanisms connecting environment and genes are becoming clearer. Cigarette smoke exposure reduces DNA methylation, a chemical process that controls which genes are turned on or off during development. When methylation patterns go wrong in the genes responsible for palate formation, it can silence genes needed for the tissue shelves to grow and fuse properly. Exposure to certain chemicals, including retinoic acid (a form of vitamin A), has been shown to cause abnormal methylation in specific palate-development genes, leading to cell death in palatal tissue and impaired fusion.
Folic Acid and Risk Reduction
Folic acid supplementation before and during early pregnancy is well established for preventing neural tube defects, and there is growing evidence it reduces cleft risk too, though the optimal dose remains debated. One study found a 65% decrease in cleft recurrence among women taking 10 mg of folic acid daily. Another found recurrence rates of 0.8% in women taking 4 mg compared to 2.9% in those taking the standard 0.4 mg dose, specifically for cleft lip with palate.
No official folic acid dose has been established specifically for cleft prevention. Researchers have proposed standardizing the dose at 5 mg for recurrence prevention, mirroring the approach used for neural tube defects. For women with a family history of clefting, discussing higher-dose supplementation with a healthcare provider before conception is a practical step.
Why Prenatal Detection Is Difficult
Cleft lip is relatively easy to spot on a standard anatomy ultrasound, typically performed between weeks 20 and 22 of pregnancy. Cleft palate alone, however, is notoriously hard to detect. Detection rates for isolated cleft palate on standard 2D ultrasound range from 0% to just 11% across studies, with one Swiss university center reporting a detection rate of only 2%. Even when a cleft palate is suspected on ultrasound, the diagnostic accuracy was just 50% in that same study.
This means most isolated cleft palates are discovered at birth. If you have a family history of clefting or other risk factors, specialized 3D ultrasound or fetal MRI may improve detection, but these are not part of routine screening. Genetic testing, including chromosomal microarray analysis, can identify syndromic causes like 22q11.2 deletion during pregnancy if there’s reason to look for them.
What Genetic Counseling Can Clarify
For families with a history of cleft palate, genetic counseling can help distinguish between syndromic and nonsyndromic causes, which makes a significant difference in predicting recurrence. If a specific syndrome is identified, targeted genetic testing can determine whether a parent carries the causative mutation and what the odds are for future children. For nonsyndromic cases, counselors use empirical recurrence data (like the Danish study figures above) combined with family history to estimate risk. The more affected relatives in a family, the higher the underlying genetic load and the greater the chance of recurrence.